Competitive Technologies' Calmare(R) Pain Therapy Medical Device Garners Media Attention

Catch up with NBC News Clone on today's hot topic: Wbna40830211 - Breaking News | NBC News Clone. Our editorial team reformatted this story for clarity and speed.

FAIRFIELD, Conn., Dec. 28, 2010 (GLOBE NEWSWIRE) -- Competitive Technologies, Inc. (OTCQX:CTTC) today announced that its Calmare® pain therapy medical device has recently garnered positive media attention, including a feature story on Salt Lake City, Utah-based KSL-TV, with follow on coverage picked up by the Associated Press.

FAIRFIELD, Conn., Dec. 28, 2010 (GLOBE NEWSWIRE) -- Competitive Technologies, Inc. (OTCQX:CTTC) today announced that its Calmare® pain therapy medical device has recently garnered positive media attention, including a feature story on Salt Lake City, Utah-based KSL-TV, with follow on coverage picked up by the Associated Press.

"The KSL-TV coverage focused on successful Calmare® treatments received by a Utah teenager who was struck by lightening in October and had suffered from debilitating chronic pain ever since," said Johnnie D. Johnson, CTTC's Chief Executive Officer. "We are very pleased to learn how successful Dr. Chalmers has been in treating patients with our Calmare® device at his Spero Pain Relief Therapy clinic in St. George, UT. It is rewarding to play even a small part in returning quality of life to individuals who have suffered from severe pain."

The archived video from the KSL-TV coverage can be found here: . The AP version is available here: .

About Competitive Technologies

Competitive Technologies, established in 1968, provides distribution, patent and technology transfer, sales and licensing services focused on the needs of its customers and matching those requirements with commercially viable product or technology solutions. CTTC is a global leader in identifying, developing and commercializing innovative products and technologies in life, electronic, nano, and physical sciences developed by universities, companies and inventors. Currently, CTTC's principal technology is the non-invasive Calmare® pain therapy medical device, which uses the biophysical "Scrambler Therapy" technology, and was developed in Italy by CTTC's client, Professor Giuseppe Marineo. The Calmare® device is currently being manufactured for sale by CTTC's partner, GEOMC Co. Ltd. of Seoul, Korea. For more information about the device, visit www . calmarett . com. Visit CTTC's website: www . competitivetech . net

Statements made about our future expectations are forward-looking statements and subject to risks and uncertainties as described in our most recent Annual Report on Form 10-K for the year ended July 31, 2010, filed with the SEC on October 27, 2010, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.

CONTACT: IR Services, LLC Jean Wilczynski 860.434.2465 info@corpirservices.com
×
AdBlock Detected!
Please disable it to support our content.

Related Articles

Donald Trump Presidency Updates - Politics and Government | NBC News Clone | Inflation Rates 2025 Analysis - Business and Economy | NBC News Clone | Latest Vaccine Developments - Health and Medicine | NBC News Clone | Ukraine Russia Conflict Updates - World News | NBC News Clone | Openai Chatgpt News - Technology and Innovation | NBC News Clone | 2024 Paris Games Highlights - Sports and Recreation | NBC News Clone | Extreme Weather Events - Weather and Climate | NBC News Clone | Hollywood Updates - Entertainment and Celebrity | NBC News Clone | Government Transparency - Investigations and Analysis | NBC News Clone | Community Stories - Local News and Communities | NBC News Clone